Drug Screening in Neonates.
Neonatal Netw
; 35(5): 321-6, 2016.
Article
em En
| MEDLINE
| ID: mdl-27636697
ABSTRACT
Gestational substance exposure continues to be a significant problem. Neonates may be exposed to various substances including illicit drugs, prescription drugs, and other legal substances that are best not used during pregnancy because of their potential deleterious effects as possible teratogens or their potential to create dependence and thus withdrawal in the neonate. Screening the newborn for gestational substance exposure is important for both acute care and early intervention to promote the best possible long-term outcomes. This column provides insight into what is known about the extent of substance use by pregnant women, an overview of neonatal biologic matrices for drug testing, and a discussion of the legal implications of neonatal substance screening.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Complicações na Gravidez
/
Síndrome de Abstinência Neonatal
/
Detecção do Abuso de Substâncias
/
Triagem Neonatal
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Female
/
Humans
/
Newborn
/
Pregnancy
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Neonatal Netw
Assunto da revista:
ENFERMAGEM
/
PERINATOLOGIA
Ano de publicação:
2016
Tipo de documento:
Article